The Indispensable Role of 6-Iodo-4(H)-quinazolinone in Pharmaceutical Intermediates
In the dynamic landscape of pharmaceutical manufacturing, the reliable availability of high-quality chemical intermediates is paramount. These compounds serve as the foundational elements for synthesizing complex drugs, and among them, 6-Iodo-4(H)-quinazolinone holds a position of significant importance. As a specialized supplier, NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to providing this essential building block to researchers and pharmaceutical companies worldwide.
6-Iodo-4(H)-quinazolinone, identified by its CAS number 16064-08-7, is a key pharmaceutical intermediate primarily recognized for its role in the synthesis of Lapatinib, a critical targeted therapy for certain cancers. Its physical form is described as a brown powder, with a melting point indicating its stability and purity. The consistent supply of this intermediate is crucial for pharmaceutical companies aiming to optimize their R&D pipelines and ensure the efficient production of APIs. The price of such intermediates can be influenced by various factors, including manufacturing complexity and market demand, making it essential for companies to secure dependable sourcing partners.
The chemical significance of quinazoline derivatives like 6-Iodo-4(H)-quinazolinone extends to their versatility in advanced organic synthesis. These compounds are vital for researchers exploring new medicinal chemistry pathways and developing novel therapeutic agents. The emphasis on stringent quality control standards ensures that each batch of this intermediate meets the required specifications for pharmaceutical applications. This commitment to quality is a hallmark of leading suppliers, guaranteeing that the intermediates provided will perform reliably in the synthesis of complex drug molecules.
NINGBO INNO PHARMCHEM CO.,LTD. understands the critical nature of its role in the pharmaceutical supply chain. By ensuring the consistent availability and high purity of 6-Iodo-4(H)-quinazolinone, the company supports the development of life-saving cancer treatments. The company's dedication to manufacturing excellence and its position as a reliable source in China contribute significantly to the progress of pharmaceutical research and drug development globally. The efficient buy of this essential chemical is a strategic move for any organization committed to innovation in healthcare.
6-Iodo-4(H)-quinazolinone, identified by its CAS number 16064-08-7, is a key pharmaceutical intermediate primarily recognized for its role in the synthesis of Lapatinib, a critical targeted therapy for certain cancers. Its physical form is described as a brown powder, with a melting point indicating its stability and purity. The consistent supply of this intermediate is crucial for pharmaceutical companies aiming to optimize their R&D pipelines and ensure the efficient production of APIs. The price of such intermediates can be influenced by various factors, including manufacturing complexity and market demand, making it essential for companies to secure dependable sourcing partners.
The chemical significance of quinazoline derivatives like 6-Iodo-4(H)-quinazolinone extends to their versatility in advanced organic synthesis. These compounds are vital for researchers exploring new medicinal chemistry pathways and developing novel therapeutic agents. The emphasis on stringent quality control standards ensures that each batch of this intermediate meets the required specifications for pharmaceutical applications. This commitment to quality is a hallmark of leading suppliers, guaranteeing that the intermediates provided will perform reliably in the synthesis of complex drug molecules.
NINGBO INNO PHARMCHEM CO.,LTD. understands the critical nature of its role in the pharmaceutical supply chain. By ensuring the consistent availability and high purity of 6-Iodo-4(H)-quinazolinone, the company supports the development of life-saving cancer treatments. The company's dedication to manufacturing excellence and its position as a reliable source in China contribute significantly to the progress of pharmaceutical research and drug development globally. The efficient buy of this essential chemical is a strategic move for any organization committed to innovation in healthcare.
Perspectives & Insights
Nano Explorer 01
“is dedicated to providing this essential building block to researchers and pharmaceutical companies worldwide.”
Data Catalyst One
“6-Iodo-4(H)-quinazolinone, identified by its CAS number 16064-08-7, is a key pharmaceutical intermediate primarily recognized for its role in the synthesis of Lapatinib, a critical targeted therapy for certain cancers.”
Chem Thinker Labs
“Its physical form is described as a brown powder, with a melting point indicating its stability and purity.”